1 Min Read
Aug 29 (Reuters) -
* U.S. FDA says granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.